Article Information
History
- February 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rama Shankar1,2,
- Mara L. Leimanis1,3,
- Patrick A. Newbury1,2,
- Ke Liu1,2,
- Jing Xing1,2,
- Derek Nedveck4,
- Eric J. Kort1,5,6,
- Jeremy W Prokop1,2,
- Guoli Zhou7,
- André S Bachmann1,
- Bin Chen1,2,* and
- Surender Rajasekaran1,3,4,*
- 1Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA
- 2Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA
- 3Pediatric Intensive Care Unit, Helen DeVos Children’s Hospital, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA
- 4Office of Research, Spectrum Health, 15 Michigan Street NE, Grand Rapids, MI 49503, USA
- 5DeVos Cardiovascular Program, Van Andel Research Institute and Fredrik Meijer Heart and Vascular Institute/Spectrum Health, Grand Rapids, MI 49503, USA
- 6Pediatric Hospitalist Medicine, Helen DeVos Children’s Hospital, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA
- 7Biomedical Research Informatics Core (BRIC), Clinical and Translational Sciences Institute (CTSI), Michigan State University, East Lansing, MI 48824, USA
- ↵*Correspondence: Dr. Bin Chen (chenbi12{at}msu.edu) and Dr. Surender Rajasekaran (surender.rajasekaran{at}spectrumhealth.org)
Posted February 20, 2020.
Gene expression signatures identify pediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unit
